New initiative to INDICATE cancer risk
- Published on
I am proud to be part of a new international collaborative initiative, called INDICATE, to unravel the role of the Human Leukocyte Antigen type as a cancer risk modifier in individuals with Lynch syndrome.
Further developments within the project will be regularly posted on the INDICATE website.
- See HITS press release.
- See Ärzteblatt.
- See IDW press release.
- See DKFZ press release.
- See EMCL news.
- See ATB news.
- Authors
- Name
- Saskia Haupt
- @HauptSaskia
